Skip to main content

Table 1 Summary of variables included in the propensity score a

From: Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study

Type of patient characteristic

Covariates included

General Covariates

Demographics

49 Total Covariates including: Age (5-year categories), Sex, self-reported Race, Ethnicity, Marital Status, Income, Disability Status, Distance to VHA facility, Urban/Rural hospital location, and Year of Medication Start

Psychiatric Covariates b

Presenting Diagnosis

9 Variables, including Bipolar I, Bipolar II, Bipolar NOS, Major Depression, Depression NOS, Schizophrenia, Schizoaffective Disorder and Other Psychoses

General Utilization

74 Covariates, including Total VHA Mental Health (MH) Provider Visits x 6 time periods, Total MH hospitalizations x 2 time periods, and Total Diagnostic Interviews, Total Medication Management Visits, Total Individual Psychotherapy Visits, Total Group Psychotherapy Visits (all x 2 time periods), and Total Current MH Medications, Recently Discontinued MH medications, and Possibly Discontinued MH medications

Comorbid Diagnoses

46 Covariates including PTSD, Other Anxiety Disorders, Adjustment Disorders, Personality Disorders, Somatoform Disorders, Impulse Control Disorders, Sleep Disorders, Eating Disorders, Sexual Disorders, Delusional Disorder, ADHD, Development Disorders, Cognitive Disorder NOS, and Dissociative Disorder

Comorbid Substance Abuse Diagnoses

41 Covariates, including 4 Covariates (Abuse, Dependence, Remission from Abuse, and Remission from Dependence for each of the following: Alcohol, Amphetamines, Cocaine, Marijuana, Opioids, Sedatives, Other), with other covariates for Hallucinogen Abuse/Dependence/Remission, Combined Drug Dependence and Remission from Combined Drug Dependence, with and without opioids, Unspecified Dependence, and Alcohol intoxication and Alcohol or Drug psychoses

Suicidal Behavior Diagnoses

9 Covariates, designating if Suicidal Behavior was diagnosed during Nonmental Health hospitalizations, Mental Health hospitalizations, or as an Outpatient, x 3 time periods (0-30 days, 31-180 days, or 181-365 days prior to Lithium or Valproate initiation)

Psychiatric Hospitalizations

10 Covariates, including Covariates designating whether patient was an Inpatient on Start Date, discharged within the last 7 days, 8-30 days, 31-180 days, and 181-365 days, the type of latest hospitalization (Psychiatric, Substance Abuse, Residential/Day program, Domiciliary), and whether any hospitalizations in the last year involved an AMA (Against Medical Advice) discharge

Specific Outpatient Utilization

48 Covariates (all modeled as 0 visits, 1 visits, or 2+ visits): General Mental Health clinic, Psychiatry visits, Psychotherapy visits, Substance Use Disorder visit, Primary Care Mental Health clinic, Health Care for Homeless Veterans, and Substance Abuse and non-Substance Abuse visits, x 2 time periods (0-180 days and 181-365 days)

Current Medications

24 Covariates, including Olanzapine, Risperidone, Quetiapine, Ziprasidone, Aripiprazole, Clozapine, First Generation Antipsychotics, Other Mood Stabilizers, SSRIs, SNRIs, Bupropion, Mirtazapine, TCAs, MAOIs, Benzodiazepines, other Hypnotics, Stimulants, Substance Abuse treatments, and other medications

Recent Medications

24 covariates, designating prescriptions received in last 180 days for same medication categories as “Current Medications,” but for which the patients’ prescribed supply does not extend to the Lithium/Valproate start date

Prior Treatment History

Prior treatment with Any Mood Stabilizer, Prior treatment with Lithium or Valproate

Geographic Suicide Risk

5 variables designating quintiles of Age-Adjusted State Suicide Rates (2000-2007)

Nonpsychiatric Variables of Possible Particular Relevance to Suicide Risk b

Nonpsychiatric Diagnoses

7 covariates, including any Acute Injury, any Fracture, Blood Vessel injury, Internal injuries, Open Wounds, Poisoning, Inhalation/Drowning/Asphyxiation injury

Nonpsychiatric Utilization

6 covariates, including Pain Clinic visits (0, 1, 2+) x 2 time periods

Nonpsychiatric Medications

4 variables, including current Opiate Pain Medicine, recent Opiate Pain Medicine, and 2 types of overdose antidotes

Also Included b:

Numerous covariates designating Nonpsychiatric Diagnoses, Nonpsychiatric Hospitalizations, Nonpsychiatric VHA Utilization (both the general amount of Nonpsychiatric VHA care received and specific clinics attended and/or care received ), Nonpsychiatric Medications (current and recent), and Nonpsychiatric Diagnostic Tests.

3 covariates recording prior VHA pharmacy use (any prior use, use in the last 180 days, and use in the last 365 days) were also included to help balance the extensiveness of pharmacy records among recipients.

  1. aPrevalence of each covariate balanced within a standardized difference of < 0.018 in final matched cohort.
  2. bAll covariates except Demographics relate to care and/or diagnoses made by providers in the VHA health system.
  3. ADHD = Attention Deficit Hyperactivity Disorder; AMA = Against Medical Advice; MAOI = Monoamine Oxidase Inhibitor; MH = Mental Health; NOS = “Not Otherwise Specified”; PTSD = Post-Traumatic Stress Disorder; SNRI = Serotonin-Norepinephrine Reuptake Inhibitor; SSRI = Serotonin-Specific Reuptake Inhibitor; TCA = Tricyclic Antidepressant; VHA = Veterans Health Administration.